afatinib
ItalyDrugs containing this active substance
-
It is used to treat adult patients with a specific type of lung cancer (non-small cell carcinoma) that has an EGFR gene mutation or is of the squamous type and has not responded to previous chemotherapies.
Form: tablets, film-coated
Active substance Dosage afatinib - ATC: L01EB03
Manufacturer: BOEHRINGER INGELHEIM INTERNATIONAL GMBH